Plain-English translation of NCT06138067 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether extra personalized support from a patient navigator can help more cancer patients enroll in clinical trials. You would be randomly assigned to receive either a standard level of support (printed materials about clinical trials) or a higher level of support (printed materials plus one-on-one help from a navigator to overcome barriers to participation). The study wants to see which approach works better at helping eligible patients join available cancer treatment trials.
Many people with cancer who could benefit from clinical trials don't enroll, even when a trial is available for them. Researchers believe that personalized support from a patient navigator — someone trained to help you understand your options and address your concerns — might help more people participate in these potentially life-saving studies.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to either a standard support group or a higher-support group. In the standard group, you'll receive printed educational materials about clinical trials. In the higher-support group, you'll receive those same materials, and a patient navigator will also meet with you (within one week of talking to your doctor) to understand what barriers might prevent you from joining a trial and help you overcome them. The main thing researchers measure is whether you choose to enroll in a clinical trial that's offered to you.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States